Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-01
DOI
10.3389/fimmu.2021.667354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bacterial and eukaryotic extracellular vesicles and non-alcoholic fatty liver disease: new players in the gut-liver axis?
- (2021) Alexandre Villard et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model
- (2021) Natalia Muñoz-Durango et al. Frontiers in Immunology
- Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
- (2021) Shireen Mohammad et al. Frontiers in Immunology
- TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis
- (2021) Jinchao Hou et al. JOURNAL OF CLINICAL INVESTIGATION
- Extracellular Vesicles as Inflammatory Drivers in NAFLD
- (2021) Akshatha N. Srinivas et al. Frontiers in Immunology
- Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery
- (2021) Fu Chen et al. Frontiers in Endocrinology
- Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
- (2021) Ronan Thibaut et al. FEBS Journal
- Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients
- (2021) Isabel Belinchón-Romero et al. Scientific Reports
- Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis
- (2021) Nahum Méndez-Sánchez et al. Frontiers in Immunology
- Management of NAFLD patients with advanced fibrosis
- (2021) Douglas Maya‐Miles et al. LIVER INTERNATIONAL
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
- (2020) Javier Ampuero et al. JOURNAL OF HEPATOLOGY
- Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
- (2020) Paolo Gisondi et al. Frontiers in Pharmacology
- Multidimensional Impact of Mediterranean Diet on IBD Patients
- (2020) Fabio Chicco et al. INFLAMMATORY BOWEL DISEASES
- Lytic cell death in metabolic liver disease
- (2020) Jérémie Gautheron et al. JOURNAL OF HEPATOLOGY
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort
- (2020) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
- (2020) Nahum Méndez-Sánchez et al. Annals of Translational Medicine
- The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
- (2020) Aleksandra Deczkowska et al. CELL
- Hsd17b13 Deficiency Does not Protect Mice From Obesogenic Diet Injury
- (2020) Yanling Ma et al. HEPATOLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- (2020) Austin Lin et al. INFLAMMATORY BOWEL DISEASES
- Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
- (2020) Susanne Gaul et al. JOURNAL OF HEPATOLOGY
- Bacterial antigen translocation and age as BMI‐independent contributing factors on systemic inflammation in NAFLD patients
- (2020) Isabel Gómez‐Hurtado et al. LIVER INTERNATIONAL
- Genetic variant rs72613567 of HSD17B13 gene reduces alcohol‐related liver disease risk in Chinese Han population
- (2020) Haizhen Chen et al. LIVER INTERNATIONAL
- TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
- (2020) Aitor Esparza-Baquer et al. GUT
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise
- (2020) Lihong Wu et al. Hepatology International
- Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver
- (2020) Anneleen Remmerie et al. IMMUNITY
- Role of fructose in NASH defined
- (2020) Shimona Starling Nature Reviews Endocrinology
- Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis
- (2020) Jenny Lee et al. PLoS One
- Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?
- (2020) Mikkel Breinholt Kjær et al. Expert Review of Gastroenterology & Hepatology
- Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation
- (2020) Kira L. Diehl et al. Cells
- Immunological mechanisms and therapeutic targets of fatty liver diseases
- (2020) Hua Wang et al. Cellular & Molecular Immunology
- The health impact of MAFLD, a novel disease cluster of NAFLD, is amplified by the integrated effect of fatty liver disease related genetic variants
- (2020) Zhenqiu Liu et al. Clinical Gastroenterology and Hepatology
- RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
- (2020) Marta B Afonso et al. GUT
- Cell Death in Liver Diseases: A Review
- (2020) Layla Shojaie et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
- (2020) Carmelo Luci et al. Frontiers in Endocrinology
- Evidence for liver and peripheral immune cells secreting tumor-suppressive extracellular vesicles in melanoma patients
- (2020) Jung-Hyun Lee et al. EBioMedicine
- Function of TREM1 and TREM2 in Liver-Related Diseases
- (2020) Huifang Sun et al. Cells
- Comparative Analysis of the Transcriptome, Proteome, and miRNA Profile of Kupffer Cells and Monocytes
- (2020) Andrey Elchaninov et al. Biomedicines
- Maternal High-Fat Diet Leads to Non-alcoholic Fatty Liver Disease Through Upregulating Hepatic SCD1 Expression in Neonate Rats
- (2020) Baige Cao et al. Frontiers in Nutrition
- Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
- (2020) Yunfei Luo et al. Immunity Inflammation and Disease
- Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis
- (2020) Bubu A. Banini et al. HEPATOLOGY
- A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms
- (2019) Rasha El Sharkawy et al. Scientific Reports
- Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation
- (2019) Masatoshi Yamato et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease
- (2019) Zi-Yuan Zou et al. INFLAMMATORY BOWEL DISEASES
- Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease
- (2019) Mirella Pastore et al. Frontiers in Pharmacology
- Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk
- (2019) David Romero-Pérez et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- High prevalence of non‐alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors
- (2019) C. Durán‐Vian et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Resolving the fibrotic niche of human liver cirrhosis at single-cell level
- (2019) P. Ramachandran et al. NATURE
- Adaptive immunity: an emerging player in the progression of NAFLD
- (2019) Salvatore Sutti et al. Nature Reviews Gastroenterology & Hepatology
- Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2019) Bishuang Cai et al. Cell Metabolism
- Tolerogenic properties of liver macrophages in non‐alcoholic steatohepatitis
- (2019) Lorenzo A. Orci et al. LIVER INTERNATIONAL
- Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis
- (2018) Dirk J. van der Windt et al. HEPATOLOGY
- IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn’s Disease
- (2018) Tracey G Simon et al. INFLAMMATORY BOWEL DISEASES
- Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease
- (2018) Alessandro Sartini et al. Cell Death & Disease
- Association of Psoriasis With Comorbidity Development in Children With Psoriasis
- (2018) Megha M. Tollefson et al. JAMA Dermatology
- DAP12/TREM2 Expression by Mouse and Human Liver DC: Functional Implications and Regulation of Liver Ischemia-Reperfusion Injury
- (2018) Toshimasa Nakao et al. HEPATOLOGY
- Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease
- (2018) Carlos J. Pirola et al. JOURNAL OF LIPID RESEARCH
- Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease
- (2017) Salvatore Petta et al. HEPATOLOGY
- MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat
- (2017) Giovanni Musso et al. HUMAN MOLECULAR GENETICS
- CD44 is a key player in non-alcoholic steatohepatitis
- (2017) Stéphanie Patouraux et al. JOURNAL OF HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease
- (2017) Sidsel Rødgaard-Hansen et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms
- (2016) J. E. Nelson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
- (2016) Konstantin Kazankov et al. LIVER INTERNATIONAL
- Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice
- (2015) Shufei Zang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue
- (2015) Li Fen Liu et al. DIABETOLOGIA
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery
- (2015) Konstantin Kazankov et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology: Table I.
- (2015) Pablo Engel et al. JOURNAL OF IMMUNOLOGY
- Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
- (2015) Mohammed Eslam et al. Nature Communications
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Is serum Interleukin-17 associated with early atherosclerosis in obese patients?
- (2014) Giovanni Tarantino et al. Journal of Translational Medicine
- IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice
- (2013) Isaac T.W. Harley et al. HEPATOLOGY
- Dendritic cells in liver injury and fibrosis: Shortcomings and promises
- (2013) Veronika Lukacs-Kornek et al. JOURNAL OF HEPATOLOGY
- CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance
- (2013) Hong Soon Kang et al. PLoS One
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- (2010) Kouichi Miura et al. GASTROENTEROLOGY
- Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2009) W. Huang et al. DIABETES
- Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
- (2008) M Sumarac-Dumanovic et al. INTERNATIONAL JOURNAL OF OBESITY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started